Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00356304 · ClinicalTrials.gov registry record · Phase 1
Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With Depression
A Phase 1 study of Depression, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00356304 is a Phase 1 study of Depression that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 50 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00356304, a Phase 1 study of Depression, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the effectiveness of motivational interviewing in improving antidepressant medication adherence among Hispanics.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as usual
- BEHAVIORAL Motivational interviewing
Study Locations (1)
New Jersey
- University Behavioral Healthcare - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-04 |
| Est. Completion | 2010-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00356304
The ClinicalTrials.gov registry entry for NCT00356304 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.
NCT00356304 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT00356304 about?
NCT00356304 is a clinical study titled "Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With Depression". This study will determine the effectiveness of motivational interviewing in improving antidepressant medication adherence among Hispanics.
What is the current status of trial NCT00356304?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2006-04. Estimated completion is 2010-07.
What conditions does trial NCT00356304 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00356304?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), Motivational interviewing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00356304?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00356304 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
RECRUITING · Phase 1
-
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
RECRUITING · Phase 1
-
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
RECRUITING · Phase 1
-
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.